levofloxacin has been researched along with Bacterial Skin Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Aozasa, N; Fukano, H; Ishii, N; Miyamoto, Y; Murakami, T; Nakamura, K; Tsunemi, Y | 1 |
| Brites, MM; Calado, R; Cardoso, JC; Relvas, M | 1 |
| Erber, J; Rothe, K; Schmid, RM; Schneider, J; Spinner, CD; Tschaikowsky, T; Weidlich, S | 1 |
| Xie, H; Yuan, HL; Zhang, W; Zheng, YY | 1 |
| Fukushima, S; Ichihara, A; Ihn, H; Inoue, Y; Jinnin, M | 1 |
| Chen, YH; Hsueh, PR; Huang, CH; Lai, CC | 1 |
| Babarina, MB; Sokolova, VI; Sychev, DA; Zaikov, DA | 1 |
| Amano, A; Ikeda, F; Ishii, R; Kanayama, S; Matsumoto, S; Matsumoto, T; Matsuzaki, K; Nakajima, A; Okamoto, K | 1 |
| Blatun, LA; Terekhova, RP | 1 |
| Fujita, N; Hatamochi, A; Kakuta, M; Matsumoto, F; Matsushima, H; Shinkai, H; Utani, A | 1 |
| Bormann, G; Marsch, WC | 1 |
| Blatun, LA; Iakovlev, VP; Svetukhin, AM; Ukhin, SA | 1 |
| Ishii, M; Nakagawa, K; Tsuruta, D | 1 |
| Iijima, S; Otsuka, F; Saito, J | 1 |
| Berman, AL; Chow, AT; Corrado, M; Dornseif, B; Drusano, GL; Fowler, CL; Natarajan, J; Preston, SL; Reichl, V | 1 |
| Jasovich, A; Neto, W; Nicodemo, AC; Robledo, JA | 1 |
| Rajacic, Z; Trampuz, A; Wenk, M; Zimmerli, W | 1 |
| Garvin, CG; Jung, R; Martin, SJ | 1 |
| Breen, JD; Brown, MJ; Champlin, J; Jones, TM; Miskin, BM; Tarshis, GA; Wingert, KJ | 1 |
4 review(s) available for levofloxacin and Bacterial Skin Diseases
| Article | Year |
|---|---|
The potential role of nemonoxacin for treatment of common infections.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Clostridium Infections; Community-Acquired Infections; Drug Therapy, Combination; Gonorrhea; Humans; Levofloxacin; Pneumonia, Bacterial; Quinolones; Skin Diseases, Bacterial | 2015 |
[Levofloxacin in complex therapy of patients with skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Humans; Levofloxacin; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 2008 |
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Ciprofloxacin; Gastrointestinal Diseases; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Skin Diseases; Skin Diseases, Bacterial; Soft Tissue Infections; Urea | 2004 |
A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Drug-Related Side Effects and Adverse Reactions; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Assessment; Skin Diseases, Bacterial; Urinary Tract Infections | 2001 |
4 trial(s) available for levofloxacin and Bacterial Skin Diseases
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.
Topics: Adult; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Bayes Theorem; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1998 |
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases, Bacterial; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 1998 |
Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcus aureus; Treatment Outcome | 2001 |
12 other study(ies) available for levofloxacin and Bacterial Skin Diseases
| Article | Year |
|---|---|
Successful treatment of cutaneous Mycobacterium chelonae infection by switching from levofloxacin to sitafloxacin.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Levofloxacin; Mycobacterium chelonae; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial | 2023 |
Acute retiform purpura caused by
Topics: Acute Disease; Aged, 80 and over; Anti-Bacterial Agents; Bandages; Disseminated Intravascular Coagulation; Enterobacteriaceae Infections; Humans; Levofloxacin; Male; Morganella morganii; Purpura; Skin Diseases, Bacterial | 2019 |
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
Topics: Amikacin; Antitubercular Agents; Diarylquinolines; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Macrolides; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Soft Tissue Injuries; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam; Young Adult | 2020 |
Two cases of human cutaneous anthrax with massive tissue damage, severe edema, and slight injury to the liver.
Topics: Adult; Anthrax; Biopsy, Needle; Blister; Drug Therapy, Combination; Edema; Humans; Immunohistochemistry; Levofloxacin; Liver; Male; Methylprednisolone; Middle Aged; Penicillin G; Prognosis; Risk Assessment; Skin Diseases, Bacterial; Soft Tissue Injuries; Treatment Outcome; Upper Extremity | 2018 |
Case of disseminated cutaneous Mycobacterium chelonae infection mimicking cutaneous vasculitis.
Topics: Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Levofloxacin; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Vasculitis | 2014 |
[Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions].
Topics: Adult; Anti-Bacterial Agents; Bronchitis; Dose-Response Relationship, Drug; Female; Humans; Levofloxacin; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Severity of Illness Index; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2014 |
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Topics: Administration, Cutaneous; Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Child; Female; Fluoroquinolones; Humans; Japan; Levofloxacin; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolizines; Quinolones; Skin Cream; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Streptococcus pyogenes | 2016 |
Levofloxacin alone efficiently treated a cutaneous mycobacterium fortuitum infection.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Skin Diseases, Bacterial; Treatment Outcome | 2002 |
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].
Topics: Adult; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Female; Forearm; Hand Dermatoses; Humans; Levofloxacin; Lymphadenitis; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Ofloxacin; Skin; Skin Diseases, Bacterial; Sporotrichosis; Treatment Outcome | 2004 |
Successful treatment of a widespread cutaneous Mycobacterium fortuitum infection with levofloxacin.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Mycobacterium; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Skin Diseases, Bacterial; Treatment Outcome | 2006 |
Mycobacterium marinum skin infection successfully treated with levofloxacin.
Topics: Adult; Anti-Infective Agents; Humans; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Ofloxacin; Remission Induction; Skin Diseases, Bacterial | 1997 |
Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid.
Topics: Anti-Infective Agents; Blister; Body Fluids; Granulocytes; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2000 |